AVITA Medical reports second-quarter commercial revenue of $15.1 million, reflecting growth of over 29% over the same period in the prior year #WoundCare #RegenerativeMedicine #SprayOnSkin $RCEL $AVH bit.ly/46Ivguy
AVITA Medical
Medical Device
Santa Clarita, California 17,585 followers
Transforming lives by providing innovative ways of healing skin.
About us
AVITA Medical (NASDAQ: RCEL, ASX:AVH) is a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration. At the forefront of our platform is the RECELL® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. RECELL harnesses the regenerative properties of a patient’s own skin to create Spray-On Skin™ Cells, delivering a transformative solution at the point-of-care. This breakthrough technology serves as the catalyst for a new treatment paradigm enabling improved clinical outcomes. AVITA Medical also holds the exclusive rights to market, sell, and distribute PermeaDerm®, a Biosynthetic Wound Matrix, in the United States.
- Website
-
https://avitamedical.com/
External link for AVITA Medical
- Industry
- Medical Device
- Company size
- 201-500 employees
- Headquarters
- Santa Clarita, California
- Type
- Public Company
- Founded
- 2008
- Specialties
- Regenerative Medicine, Chronic Wounds, Plastic Surgery, General Surgery, Acne Scar, Scar Revisions, Dermatology, and Burn & Trauma Surgeon
Locations
-
Primary
28159 Avenue Stanford
Santa Clarita, California, US
Employees at AVITA Medical
Updates
-
AVITA Medical is thrilled to welcome Robin VanDenburgh as our new Senior Vice President of U.S. Commercial Sales, effective August 6, 2024. Robin will lead our efforts to expand market presence and drive sales growth in the U.S. Join us in welcoming Robin to the AVITA Medical family! $RCEL $AVH #AVITAMedical #RECELLGO #WoundCare #RegenerativeMedicine
-
-
Breaking News: AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care #AVITAMedical #RegenerativeMedicine #Healthcare #WoundCare #BurnCare #RECELLGO #RECELL bit.ly/3ynm9CM
-
AVITA Medical to Announce Second Quarter 2024 Financial Results #WoundCare #RegenerativeMedicine #SprayOnSkin $RCEL $AVH bit.ly/3Y0DWds
-
-
AVITA Medical Achieves Milestone with First Case Using RECELL GO @DoctorsAugusta #RECELLGO #SprayOnSkin #WoundCare #RegenerativeMedicine #FDAApproval $RCEL $AVH bit.ly/3yWQibK
-
Breaking News: FDA Approves RECELL GO™! Our next-gen device streamlines the preparation of Spray-On Skin™ Cells, delivering transformative point-of-care treatment to patients with thermal burn wounds and full-thickness skin defects. #RECELLGO #SprayOnSkin #WoundCare #RegenerativeMedicine #FDAApproval $RCEL $AVH bit.ly/3V5m7qx
-
-
AVITA Medical is proud to sponsor and exhibit the RECELL® System at the AAD Annual Meeting, 2024 #vitiligo #skinrepigmentation #RECELL #SprayonSkin #ADD2024 @AADmember https://buff.ly/3PckrJF
-
-
AVITA Medical is proud to sponsor and exhibit the RECELL® System at the 20th Annual SOCS Scientific Symposium #vitiligo #skinrepigmentation #RECELL #SprayonSkin #GVFsymposium @StepUp4Vitiligo https://buff.ly/49D118T
-
-
AVITA Medical is proud to sponsor and exhibit the RECELL® System at the 20th Annual SOCS Scientific Symposium #vitiligo #skinrepigmentation #RECELL #SprayonSkin #GVFsymposium @StepUp4Vitiligo https://buff.ly/49D118T
-
-
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement #SprayonSkin #RECELL #regeneration #skinrestoration $RCEL $AVH https://buff.ly/48DUJEF
-